Literature DB >> 11164983

Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.

F Jonsson1, G Johanson.   

Abstract

Due to the lipophilicity of many xenobiotics, the perfusion of fat tissue is of special interest in physiologically based pharmacokinetic (PBPK) modeling. In order to estimate inter- and intra-individual variability in fat tissue blood flow with exercise, a population PBPK model for toluene was fitted to experimental data from subjects exposed to toluene vapors (Carlsson, A., 1982. Exposure to toluene: uptake, distribution and elimination in man. Scand. J. Work Environ. Health 8, 43-55). Six male volunteers were exposed to 80 ppm toluene for two hours during rest and moderate to heavy exercise (50-150 W). Extensive data collection was made, including sampling of arterial blood, exhaled breath and subcutaneous fat tissue. The model was simultaneously fitted to the time courses of toluene in arterial blood, exhaled breath, and subcutaneous fat in the six individuals by Markov chain Monte Carlo (MCMC) simulation. In order to describe the experimental observations in subcutaneous fat accurately, the fat compartment was split in two. According to the analysis, the increased perfusion of perirenal fat associated with physical workload was best described if it was set to the same, elevated, level during all exercise levels, rather than scaled directly to the increase in oxygen uptake. No increase in subcutaneous fat perfusion could be detected at these exposure conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164983     DOI: 10.1016/s0300-483x(00)00356-5

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  12 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS.

Authors:  Ivelina Gueorguieva; Leon Aarons; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-29       Impact factor: 2.745

3.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

4.  Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.

Authors:  Stefan Willmann; Karsten Höhn; Andrea Edginton; Michael Sevestre; Juri Solodenko; Wolfgang Weiss; Jörg Lippert; Walter Schmitt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-03-13       Impact factor: 2.410

5.  Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation.

Authors:  Kevin McNally; Richard Cotton; John Cocker; Kate Jones; Mike Bartels; David Rick; Paul Price; George Loizou
Journal:  J Toxicol       Date:  2012-04-08

6.  Heterogeneity of human adipose blood flow.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2007-01-20

7.  The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans.

Authors:  George D Loizou; Kevin McNally; Kate Jones; John Cocker
Journal:  Front Pharmacol       Date:  2015-06-30       Impact factor: 5.810

8.  Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.

Authors:  Thierry Wendling; Swati Dumitras; Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-01       Impact factor: 2.745

9.  PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.

Authors:  David G Levitt
Journal:  BMC Anesthesiol       Date:  2002-08-15       Impact factor: 2.217

10.  Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2004-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.